Renal masses and ultrasound SIR,-While I agree with Dr Thomas Sherwood (20 December, p 682) on the value and accuracy of ultrasound in the "diagnostic pathway for patients with a renal mass," several observations should be made.
(1) Fluoroscopy is an unnecessary further investigation before the puncture of cystic lesions already identified by ultrasound.1 Diagnostic puncture may be made at the time of the ultrasound study under sonar control. Since January 1974, 55 wholly transonic lesions of the kidney have been punctured in Brighton by this technique. No false-positive or falsenegative punctures were made but in two cases greatly dilated hydronephrotic moieties of duplex kidneys were entered. These had been falsely interpreted as simple cysts at both urography and ultrasound study. The remaining lesions were shown to be simple cysts. Of 19 echogenic space-occupying lesions of the kidney, all showed pathological circulation at arteriography and all were interpreted as carcinomata by both techniques. At operation 18 were found to be renal carcinomata and one to be a hamartoma. No tumour was punctured. Before cyst puncture it has been our practice to perform a hydatid complement fixation test whenever possible. As a theoretical consideration it could be argued that hydatid complement fixation testing should be mandatory before the elective puncture of all renal cysts.
(2) It is essential to demonstrate that the whole of a space-occupying lesion identified at urography can be accounted for at the time of sonar or fluoroscopic puncture. Where there is doubt it is essential to proceed to selective renal angiography.
(3) Ultrasound provides adequate renal identification for the purpose of elective biopsy.2 As such it affords a higher return of successful "first attempt" biopsies than "blind" biopsy. It obviates repeat urography and fluoroscopic biopsy where this might have been the earlier practice.
(4) Antegrade pyelography may be effected under sonar control, the method of examination being as for renal cyst puncture.
(5) The overall accuracy of renal tumour identification has been shown to be greater than that reported by Dr Sherwood. Barnett and Morley3 identified 11 of 12 renal neoplasms, and in an objective "blind" review of sonar scans one radiologist correctly identified four out of five tumours.2
As Dr Sherwood has illustrated so ably, the ability to distinguish between solid and cystic space-occupying lesions of the kidney allows further investigation to be elective rather than blind. As can be seen in the table, we did not find significant hypomagnesaemia in these patients. However, we did detect a statistically significant increase (P<O O1) in the variance within the seizure population receiving anticonvulsant therapy. We conclude that, while there is some important effect of this therapy on magnesium metabolism, we were unable to demonstrate under the rigorous conditions of a matched paired design any significant decrease in magnesium concentration. It is possible that the differences between our findings and those of Christiansen et al are related in some combination to (1) their use of an unmatched normal outpatient control population and/or (2) the considerably less likely possibility of significant differences in the effects on magnesium metabolism of primidone, which was used for seizure treatment in only a few of the patients in the population we studied.
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